Autoantibodies against autonomic nervous tissues in Type 2 diabetes mellitus: No association with cardiac autonomic dysfunction

Experimental and Clinical Endocrinology and Diabetes

Volumn 108, Issue 3, 2000, Pages 181-186

  Schnell, O ^a   Schwarz, A ^b   Muhr Becker, D ^b   Standl, E ^b  

^a INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^b NONE

Author keywords

Diabetes mellitus; GAD; IA 2; Nervous tissue autoantibodies; Neuropathy; QT interval

Indexed keywords

AUTOANTIBODY;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARASYMPATHETIC GANGLION; PRIORITY JOURNAL; QT INTERVAL; SYMPATHETIC GANGLION;

AUTOANTIBODIES; COMPLEMENT FIXATION TESTS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ELECTROCARDIOGRAPHY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GANGLIA, PARASYMPATHETIC; GANGLIA, SYMPATHETIC; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 0034021616     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7741     Document Type: Article

References (29)

1. Aronson D, Weinrauch LA, Delia JA, Tofler GH, Burger AJ: Circadian patterns of heart rate variability, fibrinolytic activity, and hemostatic factors in diabetes mellitus with cardiac autonomic neuropathy. Am J Cardiol 84: 449-453, 1999
2. Bazett HC: An anaylsis of the time-relations of electrocardiograms. Heart 7: 353-370, 1920
3. Cachia MJ, Peakman M, Zanome M, Watkins PJ, Vergani D: Reproducibility and persistence of neural and adrenal autoantibodies in diabetic autonomie neuropathy. Diabetic Med 14: 461-465, 1997
4. Dittler J, Seidel D, Schenker M, Ziegler A-G: GADIA-2-Combi Determination as First Line Screening for improved prediction of Type 1 diabetes in relatives. Diabetes 47: 592-597, 1998
5. Gilbey SG, Guy RJ, Jones G, Vergani D, Watkins PJ: Diabetes and autonomie neuropathy: An immunological association? Diabetic Med 3: 241-245, 1986
6. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A: A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboylase antibodies in childhood IDDM. Diabetologia 37: 344-350, 1994
7. Guy RJC, Richards F, Edmonds ME, Watkins PJ: Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause. British Medical Journal 289: 343-345, 1984
8. Khafagi FA, Shapiro B, Fig LM, Malette S, Sisson JC: Labetol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 30: 481-489, 1989
9. Meier M, Muhr D, Weiss M, Standl E, Schnell O: QTc interval and scintigraphically assessed myocardial perfusion in newly diagnosed and long-term type 1 diabetes mellitus. J Diab Compl, in press
10. Muhr D, Mollenhauer U, Ziegler A, Haslbeck M, Standl E, Schnell O: Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy. Diabetes Care 20: 1009-1012, 1996
11. Muhr-Becker D, Ziegler AG, Druschky A, Wolfram G, Haslbeck M, Neundörfer B, Standl E, Schnell O: Evidence for specific autoimmunity against sympathetic and parasympathetic nervous tissues in Type 1 diabetes meelitus and the relation to cardiac autonomie dysfunction. Diabetic Medicine 15: 467-472, 1998
12. Ong JJC, Sarma JSM, Venkataraman K, Levin SR, Singh BN: Circadian rhythmicity of heart rate and QTc interval in diabetic autonomie neuropathy: Implications for the mechanism of sudden death. Am Heart J 125: 744-752, 1993
13. Rabinowe SL, Brown FM, Watts M, Kadrofske MM, Vinik AI: Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM. Diabetes Care 12: 1-6, 1989
14. Rabinowe SL, Brown FM, Watts M, Smith AM: Complement-fixing antibodies to sympathetic and parasympathetic tissues in IDDM. Diabetes Care 13: 1084-1088, 1990
15. Roll U, Christie MR, Füchtenbusch M, Payton MA, Hawkes CJ, Ziegler AG: Perinatal autoimmunity in offspring of diabetic parents: the German Multicenter BABY-DIAB study: detection of humoral immune response to islet antigens in early childhood. Diabetes 45: 967-973, 1996
16. Sawicki PT, Dahne R, Bender R, Berger M: Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia 39: 77-81, 1996
17. Schnell O, Haslbeck M, Standl E: On the significance of new diagnostic approaches to cardiac autonomie neuropathy in Type 1 diabetes. Diab Stoffw 5: 127-134, 1996a
18. Schnell O, Kirsch C-M, Stemplinger J, Haslbeck M, Standl E: Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term Type 1 diabetic patients with and without ECG-based autonomie neuropathy. Diabetologia 38: 1345-1352, 1995
19. Schnell O, Muhr D, Dresel S, Tatsch K, Ziegler AG, Haslbeck M, Standl E: Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients. Diabetologia 39: 970-975, 1996b
20. Schnell O, Muhr D, Weiss M, Dresel S, Haslbeck M, Standl E: Reduced myocardial 1231-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 45: 801-805, 1996c
21. Schnell O, Stenner T, Standl E, Haslbeck M: Value of rate-corrected QT interval for the diagnosis of cardiac autonomie neuropathy in long-standing type 1 diabetes mellitus. Dtsch med Wschr 121: 819-822, 1996d
22. Sima AAF, Nathaniel V, Bril V, McEwen TAJ, Greene DA: Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81: 349-364, 1988
23. Sundkvist G, Lind P, Bergström B, Lilja B, Rabinowe SL: Autonomic nerve antibodies and autonomie nerve function in type 1 and type 2 diabetic patients. J Int Med 229:505-510, 1991
24. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, MacKay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42: 359-362, 1993
25. Veglio M, Borra M, Stevens LK, Fuller JH, Perin PC the EURODIAB IDDM Complications Study Group: The relation between QTc interval prolongation and diabetic complications. The EURODIAB EURODIAB IDDM Complications Study Group. Diabetologia 42: 68-75, 1999
26. WHO study group on diabetes: WHO technical report series: 727, 1985
27. Zanone MM, Peakman M, Purewal T, Watkins PJ, Vergani D: Autoantibodies to nervous tissue structures are associated with autonomie neuropathy in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 564-569, 1993
28. Ziegler AG, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABYDIAB Study. Diabetes 48: 460-468, 1999
29. Ziegler D, Laux G, Dannehl K, Spüler M, Mühlen H, Mayer P, Gries FA: Assessment of cardiovascular function: Age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabetic Med 9: 166-175, 1992